2017 American Transplant Congress

Monday, May 1, 2017

6:00pm-7:00pm

Clinical Outcomes in Older Kidney Transplant Recipients. A Single Center Experience.

L. Kamal, N. Hayde, P. Bedi, M. Lubetzky, M. Ajaimy, G. DeBoccardo, E. Akalin.

Poster Session C: Kidney Complications III  •  Hall D1

6:00pm-7:00pm

Combination Therapy of iNKT Cell Ligand and CD40-CD154 Signal Blockade Establishes Islet Allograft Tolerance in Non-Myeloablative Bone Marrow Transplant Recipients.

T. Kanzawa,¹ T. Hirai,¹ R. Ishii,¹ M. Okumi,¹ H. Ishida,¹ Y. Ishii,² K. Tanabe.¹

Poster Session C: Tolerance/Immune Regulation  •  Hall D1

6:00pm-7:00pm

Commonly Expressed Living Donation Fears and Concerns by Non-Directed (Altruistic) Living Kidney Donors in the United States.

A. Maghen,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² L. Kwan,¹ S. Maliski,³ J. Veale.¹

Poster Session C: Psychosocial and Treatment Adherence  •  Hall D1

6:00pm-7:00pm

Comparative Analysis of Four Surgical Techniques in More Than 700 Pancreas Transplantes in a Single Center.

M. Perosa, J. Branez, L. Mota, B. Zeballos, H. Noujaim, L. Ianhez, D. Machado, L. Alvim, M. Paredes, T. Genzini.

Poster Session C: Pancreas and Islet (Auto and Allo) Transplantation  •  Hall D1

6:00pm-7:00pm

Concurrent Psychosocial Variables Confound Perioperative and Postoperative Care in Liver Transplant Recipients with Alcoholic Liver Disease.

S. Sultan,¹ M. Hodorowicz,² J. Powell,¹ M. Connelly,¹ M. Tuten,² P. Sacco,² W. Hutson,¹ R. Barth,¹ J. LaMattina.¹

Poster Session C: Disparity in Access and Outcomes for Solid Organ Transplantation  •  Hall D1

6:00pm-7:00pm

Contributing Factors and Impact of Microbial Contamination in Human Islet Isolation and Transplantation.

R. Meier, D. Andrey, N. Niclauss, P. Sun, C. van Delden, B. Bedat, S. Demuylder-Mischler, S. Borot, P.-Y. Benhamou, A. Wojtusciszyn, N. Pernin, Y. Muller, D. Bosco, T. Berney.

Poster Session C: Pancreas and Islet (Auto and Allo) Transplantation  •  Hall D1

6:00pm-7:00pm

Controlled Donation After Circulatory Death (cDCD) Donors May Become Similar to Brain Death Donors (DBD).

C. Antoine,¹ M. Videcoq,² B. Riou,³ D. Dorez,⁴ G. Cheisson,⁵ L. Martin-Lefèvre,⁶ L. Durand,¹ E. Savoye,¹ G. Karam,² B. Barrou.³

Poster Session C: Deceased Donor Issues II: DCD, DGF, AKI, En-Bloc  •  Hall D1

6:00pm-7:00pm

Correlation of Complement Activating Donor Specific Antibodies as Measured by C3d and Cross-Match Status.

A. Babu,^1,2,3 N. Krishnan,² D. Briggs,³ D. Mitchell,¹ S. Daga.^1,2,4

Poster Session C: Antibody and B Cell  •  Hall D1

6:00pm-7:00pm

CTLA4-Ig in Combination with FTY720 Reduces the Frequency of Memory Alloreactive T Cells and Promotes Heart Allograft Survival in Sensitized Recipients.

S. Khiew,¹ J. Yang,¹ J. Young,¹ J. Chen,¹ Q. Wang,¹ D. Ying,¹ V. Vu,¹ M. Miller,² R. Sciammas,³ M.-L. Alegre,² A. Chong.¹

Poster Session C: Tolerance/Immune Regulation  •  Hall D1

6:00pm-7:00pm

DC-SIGN Functionalized Porous Silicon Nanoparticles Targeting to Human and Non-Human Primate Dendritic Cells.

S. Stead,¹ S. Kireta,² S. McInnes,³ P. Rose,¹ S. Jesudason,^1,2 S. Grey,⁴ D. Rojas-Canales,² R. Carroll,^1,2 N. Voelcker,⁴ P. Coates.^1,2

Poster Session C: Innate Immunity  •  Hall D1